Pay in 4 interest-free payments of $106.25 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
52 / / Nilotinib N-Oxide / 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) phenyl]-3-[[4-(3-pyridinyl-N-oxide)-2-pyrimidinyl]amino]benzamide
6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylate] β-D-Glucopyranuronic Acid
27 / A β-D-galactose ligand equipped with a thiol-functionalized linker through a short ethyl spacer
O-glycosylation (α-GalNAc) at Thr131 and Thr144
Galβ(1-4)Glc-PEG3-NH2
MV100052: Tris-GalNAc-PEG5-NHS Ester label-new 52 / / Nilotinib N-OxideC79H137N11O37 1832. 98 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, equipped with an N hydroxysuccinimide (NHS) activated ester through a discrete, monodisperse pentaethylene glycol (PEG5) spacer. The NHS ester reacts with primary amines to form stable amide bonds, providing a single step route to conjugate the Tri GalNAc ligand onto amine bearing payloads, antibodies,
US$ 12.00
US$ 120.00
US$ 125.95
